Synthesis, in vitro anticancer and antioxidant activity of thiadiazole substituted thiazolidin-4-ones
Acta Pharmaceutica · 01.09.2013 · 63 (3) · 397-408
DOI: 10.2478/acph-2013-0028 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Pharmaceutica, erschienen am 01.09.2013. Verfasst von Alex Joseph und 6 weiteren Autor:innen. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 27 Literaturangaben.
Abstract (Originalsprache)
A series of novel 5-alkyl/aryl thiadiazole substituted thiazolidin-4-ones were synthesized by a two-step process. In the first step, 5-alkyl/aryl substituted 2-aminothiadiazoles were synthesized, which on reaction with substituted aromatic aldehydes and thioglycolic acid in the presence of dicyclohexylcarbodiimide afforded thiazolidin- 4-ones. All the compounds were synthesized in fairly good yields and their structures were confirmed by spectral and physical data. The title compounds were screened for in vitro anti-proliferative activity on human breast adenocarcinoma cells (MCF-7) by MTT assay. Most of the derivatives showed an IC 50 less than 150 μmol L-1. Among the compounds tested, 2-(2-nitrophenyl)- 3-(5-methyl-1,3,4-thiadiazol-2-yl)-thiazolidin-4-one ( 3f) , 2-(3-fluorophenyl)-3-(5-methyl-1,3,4-thiadiazol-2- -yl)-thiazolidin-4-one ( 3b ), and 2-(4-chlorophenyl)-3- -(5-methyl-1,3,4-thiadiazol-2-yl)-thiazolidin-4-one ( 3c ) were found to be the most active derivatives with IC 50 values of 46.34, 66.84, and 60.71 μmol L -1 , respectively. Antioxidant studies of all the synthesized compounds were carried out by diphenylpicrylhydrazyl (DPPH) assay. Among the compounds tested, 2-phenyl-3-(5-styryl- -1,3,4-thiadiazol-2-yl)-thiazolidin-4-one ( 3s ) elicited superior antioxidant activity with IC 50 of 161.93 μmol L -1 .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Joseph, A., Shah, C. S., Kumar, S. S., Alex, A. T., Maliyakkal, N., Moorkoth, S., & Mathew, J. E. (2013). Synthesis, in vitro anticancer and antioxidant activity of thiadiazole substituted thiazolidin-4-ones. Acta Pharmaceutica, 63(3), 397-408. https://doi.org/10.2478/acph-2013-0028
Vancouver
Joseph A, Shah CS, Kumar SS, Alex AT, Maliyakkal N, Moorkoth S, et al. Synthesis, in vitro anticancer and antioxidant activity of thiadiazole substituted thiazolidin-4-ones. Acta Pharmaceutica. 2013;63(3):397-408. doi:10.2478/acph-2013-0028
BibTeX
@article{Joseph2013,
author = {Joseph, Alex and Shah, Chaitanyakumar S and Kumar, Suthar Sharad and Alex, Angel Treasa and Maliyakkal, Naseer and Moorkoth, Sudheer and Mathew, Jessy Elizabeth},
title = {Synthesis, in vitro anticancer and antioxidant activity of thiadiazole substituted thiazolidin-4-ones},
journal = {Acta Pharmaceutica},
year = {2013},
volume = {63},
number = {3},
pages = {397--408},
doi = {10.2478/acph-2013-0028}
}
EUVIMED